Next Generation Sequencing

Date12/14/2021 1:42:02 PM
PromoteFacebookTwitter!Report Abuse
The Foundation Medicine comprehensive genomic profiling approach leverages next generation sequencing (NGS) test technology to examine regions of the tumour genome that other tests miss. It detects both novel and known variants, including the four main classes of genomic alterations - base substitutions, insertions or deletions, copy number alterations and gene rearrangements - in a comprehensive set of cancer-relevant genes, and reports Tumour Mutational Burden (TMB) or blood Tumour Mutational Burden (bTMB), and Microsatellite Instability (MSl).

Call Roche Products (India) Pvt. Ltd. at +91-22-50457362 or visit our website page to know more about “Next Generation Sequencing”.